journal article·2021-04-21

Self-Assembled pH-Sensitive Polymeric Nanoparticles for the Inflammation-Targeted Delivery of Cu/Zn-Superoxide Dismutase

Xiangshi Sun, Kongtong Yu, Yulin Zhou, Shiyan Dong, Wenji Hu, Yating Sun, Yuhuan Li, Jing Xie, Robert J. Lee, Fengying Sun, Yifan Ma, Shengnian Wang, Betty Y. S. Kim, Yifan Wang, Zhaogang Yang, Wen Jiang, Youxin Li, Lesheng Teng

ACS Applied Materials & Interfaces· Volume 13· Issue 15
Publisher page

Abstract

The use of superoxide dismutase (SOD) is currently limited by its short half-life, rapid plasma clearance rate, and instability. We synthesized a small library of biofriendly amphiphilic polymers that comprise methoxy poly(ethylene glycol)-poly(cyclohexane-1,4-diyl acetone dimethyleneketal) (mPEG-PCADK) and mPEG-poly((cyclohexane86.7%, 1,5-pentanediol13.3%)-1,4-diyl acetone dimethylene ketal) (PK3) for the targeted delivery of SOD. The novel polymers could self-assemble into micellar nanoparticles with favorable hydrolysis kinetics, biocompatibility, long circulation time, and inflammation-targeting effects. These materials generated a better pH-response curve and exhibited better hydrolytic kinetic behavior than PCADK and PK3. The polymers showed good biocompatibility with protein drugs and did not induce an acidic microenvironment during degradation in contrast to materials such as PEG-block-poly(lactic-co-glycolic acid) (PLGA) and PLGA. The SOD that contained reverse micelles based on mPEG2000-PCADK exhibited good circulation and inflammation-targeting properties. Pharmacodynamic results indicated exceptional antioxidant and anti-inflammatory activities in a rat adjuvant-induced arthritis model and a rat peritonitis model. These results suggest that these copolymers are ideal protein carriers for targeting inflammation treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Nanoparticle-Based Drug Delivery · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Sciences, Jilin University, No.2699, Qianjin Street, Changchun, Jilin 130012, China

Zhejiang Sundoc Pharmaceutical Science and Tech Co., Ltd., Hangzhou, Zhejiang 310000, China

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States

College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States

Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio 43210, United States

College of Engineering and Science, Louisiana Tech University, Ruston, Louisiana 71272, United States

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States

References (44)

Show source-provided references
1. 10.1038/nrmicro100410.1038/nrmicro1004 ↗
2. 10.1016/s0021-9258(18)63504-510.1016/s0021-9258(18)63504-5 ↗
3. 10.1073/pnas.89.21.1040510.1073/pnas.89.21.10405 ↗
4. 10.1038/nrd280310.1038/nrd2803 ↗
5. 10.1038/nrgastro.2010.6610.1038/nrgastro.2010.66 ↗
6. 10.1016/j.pharep.2014.03.01110.1016/j.pharep.2014.03.011 ↗
7. 10.1016/s0168-3659(96)01605-710.1016/s0168-3659(96)01605-7 ↗
8. 10.1016/j.biomaterials.2016.08.01010.1016/j.biomaterials.2016.08.010 ↗
9. 10.1016/s0939-6411(02)00045-010.1016/s0939-6411(02)00045-0 ↗
10. 10.1021/bc00024a01110.1021/bc00024a011 ↗
11. 10.1134/s000629790911013310.1134/s0006297909110133 ↗
12. 10.1177/088391150505906810.1177/0883911505059068 ↗
13. 10.1016/j.ejps.2013.02.01110.1016/j.ejps.2013.02.011 ↗
14. 10.1016/j.jconrel.2013.04.02110.1016/j.jconrel.2013.04.021 ↗
15. 10.1021/acsnano.5b0387610.1021/acsnano.5b03876 ↗
16. 10.1016/j.jconrel.2014.06.04610.1016/j.jconrel.2014.06.046 ↗
17. 10.1021/nn102711d10.1021/nn102711d ↗
18. 10.1016/j.biomaterials.2009.09.10010.1016/j.biomaterials.2009.09.100 ↗
19. 10.1016/j.biomaterials.2010.02.06310.1016/j.biomaterials.2010.02.063 ↗
20. 10.1021/bc050176w10.1021/bc050176w ↗
21. 10.1016/j.biomaterials.2009.10.04510.1016/j.biomaterials.2009.10.045 ↗
22. 10.1002/jps.2117610.1002/jps.21176 ↗
23. 10.1021/bc060259s10.1021/bc060259s ↗
24. 10.1016/j.biomaterials.2016.01.06110.1016/j.biomaterials.2016.01.061 ↗
25. 10.1038/nmat285910.1038/nmat2859 ↗
26. 10.1016/j.ijpharm.2015.10.00310.1016/j.ijpharm.2015.10.003 ↗
27. 10.1021/bc700442g10.1021/bc700442g ↗
28. 10.1016/j.biomaterials.2013.06.05110.1016/j.biomaterials.2013.06.051 ↗
29. 10.1016/j.biomaterials.2008.10.03410.1016/j.biomaterials.2008.10.034 ↗
30. 10.1016/j.biomaterials.2013.02.00510.1016/j.biomaterials.2013.02.005 ↗
31. 10.1039/c1cs15233e10.1039/c1cs15233e ↗
32. 10.1016/j.jcis.2013.11.08010.1016/j.jcis.2013.11.080 ↗
33. 10.1016/j.biomaterials.2009.10.04610.1016/j.biomaterials.2009.10.046 ↗
34. 10.1016/j.jconrel.2011.06.01210.1016/j.jconrel.2011.06.012 ↗
35. 10.1016/j.addr.2013.10.00710.1016/j.addr.2013.10.007 ↗
36. 10.1016/j.carbpol.2015.04.03610.1016/j.carbpol.2015.04.036 ↗
37. 10.1016/j.biomaterials.2006.01.05410.1016/j.biomaterials.2006.01.054 ↗
38. 10.1016/j.ijpharm.2015.08.01310.1016/j.ijpharm.2015.08.013 ↗
39. 10.1016/S0169-409X(97)00051-310.1016/S0169-409X(97)00051-3 ↗
40. 10.1016/j.jconrel.2014.07.05710.1016/j.jconrel.2014.07.057 ↗
41. 10.1016/j.clinbiochem.2005.08.00810.1016/j.clinbiochem.2005.08.008 ↗
42. 10.1002/jbm.a.3306010.1002/jbm.a.33060 ↗
43. 10.1002/(sici)1097-0290(19991220)65:6<659::aid-bit6>3.0.co;2-910.1002/(sici)1097-0290(19991220)65:6<659::aid-bit6>3.0.co;2-9 ↗
44. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗